These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3514492)

  • 1. Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial.
    Gatto G; Caleri D; Michelacci S; Sicuteri F
    Int J Clin Pharmacol Res; 1986; 6(1):15-7. PubMed ID: 3514492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.
    Strous RD; Ritsner MS; Adler S; Ratner Y; Maayan R; Kotler M; Lachman H; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):14-22. PubMed ID: 18824331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment.
    Varela-Moreiras G; Alonso-Aperte E; Rubio M; Gassó M; Deulofeu R; Alvarez L; Caballería J; Rodés J; Mato JM
    Hepatology; 1995 Oct; 22(4 Pt 1):1310-5. PubMed ID: 7557886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
    Fazio C; Andreoli V; Agnoli A; Casacchia M; Cerbo R
    Minerva Med; 1973 Apr; 64(29):1515-29. PubMed ID: 4576704
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch and S-adenosylmethionine.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):316-9. PubMed ID: 3052141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled clinical study of SAMe (S-adenosylmethionine) administered orally in degenerative osteoarticular pathology].
    Cucinotta D; Mancini M; Ceccato S; Castino E
    G Clin Med; 1980 Jul; 61(7):553-66. PubMed ID: 7004982
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new drug in the treatment of migraine (therapeutic trial)].
    Marcos Lanzarot M
    Rev Clin Esp; 1970 Jul; 118(2):165-70. PubMed ID: 4924445
    [No Abstract]   [Full Text] [Related]  

  • 10. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of postconcussion syndrome with S-adenosylmethionine].
    Bacci Ballerini F; López Anguera A; Alcaraz P; Hernández Reyes N
    Med Clin (Barc); 1983 Feb; 80(4):161-4. PubMed ID: 6345953
    [No Abstract]   [Full Text] [Related]  

  • 12. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis.
    Glorioso S; Todesco S; Mazzi A; Marcolongo R; Giordano M; Colombo B; Cherie-Ligniere G; Mattara L; Leardini G; Passeri M
    Int J Clin Pharmacol Res; 1985; 5(1):39-49. PubMed ID: 3888864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 16. [Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].
    Pascual J; Láinez JM; Leira R; Titus F; Mateos V; Galván J;
    Neurologia; 2003; 18(1):7-17. PubMed ID: 12590376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Semin Cutan Med Surg; 2001 Jun; 20(2):93-100. PubMed ID: 11474749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [S-adenosylmethionine (SAM) in geriatric therapy].
    Jori E; Dallari A
    Minerva Med; 1973 Sep; 64(67):3485-91. PubMed ID: 4746873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind clinical study of the therapeutic effect of SAMe and Ibuprofen in degenerative osteoarticular pathology].
    Ceccato S; Cucinotta D; Carapezzi C; Ferretti G; Passeri M
    G Clin Med; 1980 Feb; 61(2):148-62. PubMed ID: 7004977
    [No Abstract]   [Full Text] [Related]  

  • 20. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.